Dr. Michael Kluger earned his medical degree from New York University School of Medicine. He completed his general surgery residency at NewYork-Presbyterian Hospital/Columbia University Medical Center and his surgical oncology fellowship at Henri Mondor Hospital in France.
Dr. Kluger currently practices as a surgical oncologist at New York-Presbyterian Hospital/Columbia University Medical Center. His special areas of interest include peritoneal mesothelioma, hyperthermic intraperitoneal chemotherapy (HIPEC), and cytoreduction.
People with this disease today can live significantly longer when they receive the right treatment from the start.
Dr. Kluger asserts that patients with peritoneal mesothelioma now receive better medical care than ever before, thanks to treatment with cytoreductive surgery and HIPEC. People with this disease today can live significantly longer when they receive the right treatment from the start. For this reason, Dr. Kluger urges patients to seek care at a specialty center immediately to lower the chances of misdiagnosis and mismanagement.
When facing a diagnosis of malignant peritoneal mesothelioma, it is crucial to find the right treatment right away. Contact Dr. Michael Kluger today.